United States· US:0486-1111_5cdb4128-66e9-4e90-936b-38dd8b5b8688
K Phos
A medicinal product containing potassium phosphate, monobasic, registered in United States by Beach Products, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POTASSIUM PHOSPHATE, MONOBASIC
- Manufacturer
- Beach Products, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc110486111101100 TABLET, SOLUBLE in 1 BOTTLE (0486-1111-01)
- ndc110486111105500 TABLET, SOLUBLE in 1 BOTTLE (0486-1111-05)
- ndc110486-1111-01
- ndc110486-1111-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Potassium phosphate, monobasic in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAddiphos solution for infusion 20ml vialsFresenius Kabi Ltd
- CzechiaDIHYDROGENFOSFOREČNAN DRASELNÝ ARDEAPHARMAARDEAPHARMA, a.s., Ševětín
- BelgiumKalium Fosfaat B. Braun 0.544 g/20 ml - 1.394 g/20 mlB. Braun Melsungen
- CanadaPOTASSIUM PHOSPHATE MONOBASIC INJECTIONSANDOZ CANADA INCORPORATED
- NorwayFosfato Monopotassico braunB. Braun Medical
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Dihydrogenfosforečnan Draselný Ardeapharma
- France · Phosphate Monopotassique Renaudin
- Portugal · Fosfato Monopotássico Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff031d7d-82ca-41bc-af1e-17c38bc6b2f8 GET /v1/drugs/ff031d7d-82ca-41bc-af1e-17c38bc6b2f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "500",
"substance": "POTASSIUM PHOSPHATE, MONOBASIC",
"productndc": "0486-1111",
"dosage_form": "TABLET, SOLUBLE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about potassium phosphate, monobasic.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.